advertisement
Abstract #8507 Published in IGR 5-1
Use of xalatan in unstable glaucoma in myopic patients
Makashova NVVestnik Oftalmologii 2002; 118: 44-46
Forty-one patients (79 eyes), average age 66.9 ± 4.5 years, were divided into three groups. Group 1 consisted of 20 patients (39 eyes) with primary open-angle glaucoma (POAG), with refraction emmetropy (1.0 D); group 2 included 11 cases (22 eyes) in combination with myopia; group 3 included ten patients (19 eyes) with normotensive glaucoma (NTG) and myopia. In the patients with unstabilized POAG in combination with myopia, NTG and myopia monotherapy with Xalatan (latanoprost) or combined therapy with xalatan with beta-blockers, and to a lesser extent, with Pilocarpine, was shown to stabilize the process in 35-53% of cases.LA: Russian
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)